Cargando…
Benserazide, a dopadecarboxylase inhibitor, suppresses tumor growth by targeting hexokinase 2
BACKGROUND: Hexokinase (HK) is the rate-limiting enzyme in the first reaction of glycolysis. And Hexokinase 2 (HK2) is most closely related to malignant tumor which expresses at higher level compared with normal cells. HK2 plays a pivotal role in tumor initiation and maintenance, which provides a ne...
Autores principales: | Li, Wei, Zheng, Mengzhu, Wu, Shuangping, Gao, Suyu, Yang, Mei, Li, Zhimei, Min, Qiuxia, Sun, Weiguang, Chen, Lixia, Xiang, Guangya, Li, Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5399312/ https://www.ncbi.nlm.nih.gov/pubmed/28427443 http://dx.doi.org/10.1186/s13046-017-0530-4 |
Ejemplares similares
-
Proton pump inhibitor ilaprazole suppresses cancer growth by targeting T-cell-originated protein kinase
por: Zheng, Mengzhu, et al.
Publicado: (2017) -
Structure based discovery of clomifene as a potent inhibitor of cancer-associated mutant IDH1
por: Zheng, Mengzhu, et al.
Publicado: (2017) -
Benserazide, the first allosteric inhibitor of Coxsackievirus B3 3C protease()
por: Kim, Bo-Kyoung, et al.
Publicado: (2015) -
Benserazide-induced diarrhea – A retrospective clinical study
por: Csoti, Ilona, et al.
Publicado: (2020) -
The Three Catecholics Benserazide, Catechol and Pyrogallol are GPR35 Agonists
por: Deng, Huayun, et al.
Publicado: (2013)